Login / Signup

Pigmentary mosaicism as a recurrent clinical manifestation in three new patients with mosaic trisomy 12 diagnosed postnatally: cases report and literature review.

A Martínez-HernándezD Martínez-AnayaC Durán-McKinsterV Del Castillo-RuizP Navarrete-MenesesE J CórdovaB E Villegas-TorresA Ruiz-HerreraR Juárez-VelázquezE Yokoyama-RebollarD Cervantes-BarragánA Pedraza-MeléndezL OrozcoP Pérez-VeraConsuelo Salas-Labadía
Published in: BMC medical genomics (2022)
The detailed clinical, cytogenetic, and molecular description of these three new patients, contributes with relevant information to delineate more accurately a group of patients that show a heterogeneous phenotype, although sharing the same chromosomal alteration. The possibility of detecting mosaic trisomy 12 is directly associated with the sensitivity of the methodology applied to reveal the low-level chromosomal mosaicism, as well as with the possibility to perform the analysis in a suitable tissue.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • social media
  • health information
  • single cell